Spots Global Cancer Trial Database for Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
Official Title: Bone Marker-directed Dosing of ZOMETA® (Zoledronic Acid) for the Prevention of Skeletal Complications in Patients With Advanced Multiple Myeloma.
Study ID: NCT00622505
Conditions
Interventions
Study Description
Brief Summary: This study evaluated the effectiveness and safety of a dosing method for zoledronic acid in preventing skeletal complications in multiple myeloma participants who have been on an intravenous (IV) bisphosphonate for about one to two years.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
TriValley Cancer Research and Treatment Center, Casa Grande, Arizona, United States
Wilshire Oncology Medical Group, La Verne, California, United States
Cedars Sinai Medical Center Outpatient Cancer Ctr. (4), Los Angeles, California, United States
Palo Alto Medical Foundation Hematology/Oncology, Mountain View, California, United States
Oncology Care Medical Associates, San Gabriel, California, United States
Santa Clara Valley Health & Hospital System, San Jose, California, United States
University of Colorado U of Colorado Cancer Center, Aurora, Colorado, United States
Hematology Oncology PC, Stamford, Connecticut, United States
Washington Hospital Center, Washington, District of Columbia, United States
Palm Beach Institute of Hematology Oncology, Boynton Beach, Florida, United States
Innovative Medical Research of South Florida Innovative Med Research, Miami Shores, Florida, United States
Cancer Centers of Florida PA Cancer Centers of Central FL, Ocoee, Florida, United States
Integrated Community Oncology Network Florida Oncology Associates, Orange Park, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
Loyola University Medical Center /Cardinal Bernardin Cancer Loyola Univ Med Ctr, Maywood, Illinois, United States
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
Center for Cancer & Blood Disorders, Bethesda, Maryland, United States
Oncology - Hematology Associates, PA Oncology Hematology Assoc, Clinton, Maryland, United States
Dana Farber Cancer Institute Clinical Research Coordinator, Boston, Massachusetts, United States
Boston VA Healthcare Boston VA, Boston, Massachusetts, United States
Berkshire Hematology Oncology, Pittsfield, Massachusetts, United States
N MS Hematology & Oncology, Tupelo, Mississippi, United States
Hematology & Oncology Consultants, PC Hematology & Oncology, Omaha, Nebraska, United States
Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2), Somerset, New Jersey, United States
Cooper Cancer Center, Voorhees, New Jersey, United States
Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center, Rochester, New York, United States
University of Rochester MC / James P. Wilmot Cancer Center James P. Wilmot Cancer Center, Rochester, New York, United States
SUNY - Upstate Medical University Div. of Hematology-Oncology, Syracuse, New York, United States
Carolina Oncology Specialists, PC, Hickory, North Carolina, United States
Regional Hematology-Oncology Associates PC, Langhorne, Pennsylvania, United States
Temple University Temple University, Philadelphia, Pennsylvania, United States
Medical Associates, PA, Charleston, South Carolina, United States
Low Country Hematology Oncology Dept of Lowcountry Hem/Onc, Mount Pleasant, South Carolina, United States
Lexington Oncology Associates, West Columbia, South Carolina, United States
Avera Research Institute, Sioux Falls, South Dakota, United States
Blood and Cancer Center of East Texas, Tyler, Texas, United States
East Texas Medical Center Cancer Institute, Tyler, Texas, United States
Northern Utah Cancer Associates Dept.ofNorthernUtahAssoc., Ogden, Utah, United States
Central Utah Clinic Central Utah Clinic (8), Provo, Utah, United States
Peninsula Cancer Institute, Newport News, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
West Virginia University Health Research Center Clinical Trial Research Unit, Morgantown, West Virginia, United States
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
